Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.strides.com | |
Market Cap | 3,246.83 Cr. | |
Enterprise Value(EV) | 5,705.33 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -22.44 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 32.05 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 244.98 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.46 | Calculated using Price: 357.80 |
Dividend Yield | 0.42 | Period Ending 2022-03 |
No. of Shares Subscribed | 9.03 Cr. | 90,302,704 Shares |
FaceValue | 10 | |
About Strides Pharma Science Ltd. | ||
The company's core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers. |
1 Day |
|
-0.65% |
1 Week |
|
-1.39% |
1 Month |
|
+5.07% |
3 Month |
|
+20.72% |
6 Month |
|
+4.38% |
1 Year |
|
+8.79% |
2 Year |
|
-53.11% |
5 Year |
|
-7.21% |
10 Year |
|
-59.26% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -15.37 | 0.09 | 6.22 | 10.37 | 2.86 | 3.50 | 1.68 | 9.21 | -18.49 | |
Return on Capital Employed (%) | 7.76 | 10.92 | 7.98 | 8.32 | 4.83 | 2.61 | 4.06 | 9.08 | -9.49 | |
Return on Assets (%) | -6.76 | 0.04 | 2.40 | 3.63 | 1.02 | 1.24 | 0.63 | 3.82 | -6.99 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 1,007 | 1,145 | 2,658 | 2,749 | 2,464 | 2,649 | 2,527 | 2,777 | 2,359 | 2,212 | |
Non Curr. Liab. | 306 | 286 | 2,760 | 2,049 | 2,067 | 2,343 | 814 | 1,264 | 966 | 1,210 | |
Curr. Liab. | 707 | 1,020 | 1,892 | 3,104 | 1,899 | 2,662 | 2,545 | 2,738 | 3,412 | 2,990 | |
Minority Int. | 76 | 19 | 50 | 134 | 155 | 153 | 67 | 37 | 24 | -39 | |
Equity & Liab. | 2,096 | 2,469 | 7,360 | 8,035 | 6,585 | 7,807 | 5,953 | 6,817 | 6,761 | 6,373 | |
Non Curr. Assets | 788 | 1,040 | 3,845 | 4,243 | 4,101 | 4,758 | 3,581 | 4,000 | 3,399 | 3,130 | |
Curr. Assets | 1,309 | 1,429 | 3,515 | 3,792 | 2,447 | 3,049 | 2,371 | 2,817 | 3,362 | 3,243 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2,096 | 2,469 | 7,360 | 8,035 | 6,585 | 7,807 | 5,953 | 6,817 | 6,761 | 6,373 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 1,341 | 1,196 | 2,862 | 2,755 | 2,845 | 2,178 | 2,752 | 3,316 | 3,070 | 3,688 | |
Other Income | 60 | 39 | 92 | 161 | 76 | 41 | 53 | 59 | 132 | 113 | |
Total Income | 1,401 | 1,234 | 2,954 | 2,917 | 2,921 | 2,219 | 2,805 | 3,375 | 3,202 | 3,802 | |
Total Expenditure | -1,118 | -967 | -2,448 | -2,228 | -2,431 | -1,936 | -2,236 | -2,689 | -3,090 | -3,281 | |
PBIDT | 284 | 267 | 506 | 688 | 491 | 283 | 569 | 686 | 112 | 521 | |
Interest | -109 | -47 | -168 | -183 | -196 | -79 | -156 | -150 | -177 | -261 | |
Depreciation | -56 | -64 | -131 | -126 | -154 | -117 | -174 | -206 | -233 | -243 | |
Taxation | -325 | -148 | -42 | -63 | -6 | 27 | -11 | -32 | 178 | 55 | |
Exceptional Items | -27 | -7 | -41 | -36 | -44 | 22 | -78 | 43 | -244 | -17 | |
PAT | -233 | 1 | 118 | 280 | 74 | 89 | 43 | 244 | -474 | 54 | |
Minority Interest | -1 | 1 | 14 | -46 | -20 | -5 | 6 | 11 | 14 | 10 | |
Share Associate | -285 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 1,767 | 845 | 109 | 400 | 665 | 325 | 36 | 268 | -460 | -203 | |
Adjusted EPS | 297 | 142 | 12 | 45 | 74 | 36 | 4 | 30 | -51 | -23 |
Particulars | 10 years | 2012-12 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 134 | -272 | 83 | 73 | 288 | 187 | 60 | 205 | 481 | -258 | |
Cash Fr. Inv. | 807 | 4,077 | 52 | -2,225 | -687 | 583 | -148 | 1,306 | -521 | -119 | |
Cash Fr. Finan. | -990 | -3,319 | -421 | 2,944 | 338 | -1,016 | 194 | -1,709 | -16 | 421 | |
Net Change | -49 | 487 | -286 | 792 | -60 | -246 | 106 | -199 | -55 | 45 | |
Cash & Cash Eqvt | 132 | 586 | 298 | 1,111 | 515 | 256 | 366 | 182 | 126 | 171 |
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Earnings Call transcript pertaining to Audited Financial Results for the quarter and year ended March 31 2023. |
Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for the year ended March 31 2023 |
Fri, 26 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement - Audited Financial Results for the quarter and year ended March 31 2023 |
Thu, 01 Jun 2023 |
|
|
|
|
|